Skip to main content
. 2021 Oct 26;2021:9026918. doi: 10.1155/2021/9026918

Figure 7.

Figure 7

Screening potential small molecular compounds and activated pathways associated with RS model in gastric cancer. (a) Candidate small molecular compounds that were predicted by the CMAP database based on differentially expressed EMT-related genes. X-axis shows mechanism of action, and y-axis represents small compounds. (b–d) Activated pathways in high-RS gastric cancer samples in (b) TCGA, (c) GSE66229, and (d) GSE84437 datasets.